Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling

Journal of Cell Science

Volumn 127, Issue 7, 2014, Pages 1565-1575

  Capurro, Mariana ^a   Martin, Tonya ^a   Shi, Wen ^a   Filmus, Jorge ^a  

^a Sunnybrook Health Sciences Centre   (Canada)

Author keywords

Frizzled; Glypican 3; Heparan sulphate; Hepatocellular carcinoma; Proteoglycan; Wnt

Indexed keywords

FRIZZLED PROTEIN; GLYCOSAMINOGLYCAN; GLYPICAN; GLYPICAN 3; GLYPICAN 6; PROTEOGLYCAN; UNCLASSIFIED DRUG; WNT PROTEIN; GPC3 PROTEIN, HUMAN;

ARTICLE; CELL LINE; CELL MEMBRANE; CONTROLLED STUDY; ENDOCYTOSIS; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; WNT SIGNALING PATHWAY; HEK293 CELL LINE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PHYSIOLOGY;

CARCINOMA, HEPATOCELLULAR; FRIZZLED RECEPTORS; GLYPICANS; HEK293 CELLS; HUMANS; LIVER NEOPLASMS; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84897462045     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.140871     Document Type: Article

References (55)

1. Akiyama, T., Kamimura, K., Firkus, C., Takeo, S., Shimmi, O. and Nakato, H. (2008). Dally regulates Dpp morphogen gradient formation by stabilizing Dpp on the cell surface. Dev. Biol. 313, 408-419.
2. Ayers, K. L., Gallet, A., Staccini-Lavenant, L. and Thèrond, P. P. (2010). The long-range activity of Hedgehog is regulated in the apical extracellular space by the glypican Dally and the hydrolase Notum. Dev. Cell 18, 605-620.
3. Belenkaya, T. Y., Han, C., Yan, D., Opoka, R. J., Khodoun, M., Liu, H. and Lin, X. (2004). Drosophila Dpp morphogen movement is independent of dynaminmediated endocytosis but regulated by the glypican members of heparan sulfate proteoglycans. Cell 119, 231-244.
4. Bengochea, A., de Souza, M. M., Lefrançois, L., Le Roux, E., Galy, O., Chemin, I., Kim, M., Wands, J. R., Trepo, C., Hainaut, P. et al. (2008). Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br. J. Cancer 99, 143-150.
5. Bilic, J., Huang, Y. L., Davidson, G., Zimmermann, T., Cruciat, C. M., Bienz, M. and Niehrs, C. (2007). Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. Science 316, 1619-1622.
6. Blitzer, J. T. and Nusse, R. (2006). A critical role for endocytosis in Wnt signaling. BMC Cell Biol. 7, 28.
7. Bruix, J., Sherman, M.; American Association for the Study of Liver Diseases (2011). Management of hepatocellular carcinoma: an update. Hepatology 53, 1020-1022.
8. Buraschi, S., Pal, N., Tyler-Rubinstein, N., Owens, R. T., Neill, T. and Iozzo, R. V. (2010). Decorin antagonizes Met receptor activity and down-regulates bcatenin and Myc levels. J. Biol. Chem. 285, 42075-42085.
9. Caneparo, L., Huang, Y. L., Staudt, N., Tada, M., Ahrendt, R., Kazanskaya, O., Niehrs, C. and Houart, C. (2007). Dickkopf-1 regulates gastrulation movements by coordinated modulation of Wnt/b catenin and Wnt/PCP activities, through interaction with the Dally-like homolog Knypek. Genes Dev. 21, 465-480.
10. Capurro, M., Wanless, I. R., Sherman, M., Deboer, G., Shi, W., Miyoshi, E. and Filmus, J. (2003). Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 125, 89-97.
11. Capurro, M. I., Xiang, Y. Y., Lobe, C. and Filmus, J. (2005). Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer Res. 65, 6245-6254.
12. Capurro, M. I., Xu, P., Shi, W., Li, F., Jia, A. and Filmus, J. (2008). Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding. Dev. Cell 14, 700-711.
13. Capurro, M. I., Li, F. and Filmus, J. (2009). Overgrowth of a mouse model of Simpson-Golabi-Behmel syndrome is partly mediated by Indian hedgehog. EMBO Rep. 10, 901-907.
14. Clevers, H. (2006). Wnt/b-catenin signaling in development and disease. Cell 127, 469-480.
15. Desbordes, S. C. and Sanson, B. (2003). The glypican Dally-like is required for Hedgehog signalling in the embryonic epidermis of Drosophila. Development 130, 6245-6255.
16. Dwivedi, P. P., Grose, R. H., Filmus, J., Hii, C. S. T., Xian, C. J., Anderson, P. J. and Powell, B. C. (2013). Regulation of bone morphogenetic protein signalling and cranial osteogenesis by Gpc1 and Gpc3. Bone 55, 367-376.
17. Fico, A., De Chevigny, A., Egea, J., Bösl, M. R., Cremer, H., Maina, F. and Dono, R. (2012). Modulating Glypican4 suppresses tumorigenicity of embryonic stem cells while preserving self-renewal and pluripotency. Stem Cells 30, 1863-1874.
18. Filmus, J. and Capurro, M. (2012). The glypican family. In Extracellular Matrix: Pathobiology and Signaling (ed. N. K. Karamanos), pp. 209-220. Berlin/Boston: De Gruyter.
19. Filmus, J., Capurro, M. and Rast, J. (2008). Glypicans. Genome Biol. 9, 224.
20. Fujise, M., Takeo, S., Kamimura, K., Matsuo, T., Aigaki, T., Izumi, S. and Nakato, H. (2003). Dally regulates Dpp morphogen gradient formation in the Drosophila wing. Development 130, 1515-1522.
21. Gallet, A., Staccini-Lavenant, L. and Thèrond, P. P. (2008). Cellular trafficking of the glypican Dally-like is required for full-strength Hedgehog signaling and wingless transcytosis. Dev. Cell 14, 712-725.
22. Gonzalez, A. D., Kaya, M., Shi, W., Song, H., Testa, J. R., Penn, L. Z. and Filmus, J. (1998). OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner. J. Cell Biol. 141, 1407-1414.
23. Gordon, M. D. and Nusse, R. (2006). Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J. Biol. Chem. 281, 22429-22433.
24. Grumolato, L., Liu, G., Mong, P., Mudbhary, R., Biswas, R., Arroyave, R., Vijayakumar, S., Economides, A. N. and Aaronson, S. A. (2010). Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev. 24, 2517-2530.
25. Gutièrrez, J. and Brandan, E. (2010). A novel mechanism of sequestering FGF-2 by glypican in lipid rafts, allowing skeletal muscle differentiation. Mol. Cell. Biol. 30, 1634-1649.
26. Han, C., Belenkaya, T. Y., Wang, B. and Lin, X. (2004). Drosophila glypicans control the cell-to-cell movement of Hedgehog by a dynamin-independent process. Development 131, 601-611.
27. Ibrahimi, O. A., Zhang, F., Hrstka, S. C., Mohammadi, M. and Linhardt, R. J. (2004). Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly. Biochemistry 43, 4724-4730.
28. Kamimura, K., Ueno, K., Nakagawa, J., Hamada, R., Saitoe, M. and Maeda, N. (2013). Perlecan regulates bidirectional Wnt signaling at the Drosophila neuromuscular junction. J. Cell Biol. 200, 219-233.
29. Kern, M. A., Breuhahn, K. and Schirmacher, P. (2002). Molecular pathogenesis of human hepatocellular carcinoma. Adv. Cancer Res. 86, 67-112.
30. Kreuger, J., Perez, L., Giraldez, A. J. and Cohen, S. M. (2004). Opposing activities of Dally-like glypican at high and low levels of Wingless morphogen activity. Dev. Cell 7, 503-512.
31. Li, F., Shi, W., Capurro, M. and Filmus, J. (2011). Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating Hedgehog signaling. J. Cell Biol. 192, 691-704.
32. Li, L., Jin, R., Zhang, X., Lv, F., Liu, L., Liu, D., Liu, K., Li, N. and Chen, D. (2012). Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma. Hepatology 56, 1380-1390.
33. Libbrecht, L., Severi, T., Cassiman, D., Vander Borght, S., Pirenne, J., Nevens, F., Verslype, C., van Pelt, J. and Roskams, T. (2006). Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Am. J. Surg. Pathol. 30, 1405-1411.
34. Lum, L., Yao, S., Mozer, B., Rovescalli, A., Von Kessler, D., Nirenberg, M. and Beachy, P. A. (2003). Identification of Hedgehog pathway components by RNAi in Drosophila cultured cells. Science 299, 2039-2045.
35. Marrero, J. A. (2009). Modern diagnosis of hepatocellular carcinoma: Utilization of liver biopsy and genomic markers. J. Hepatol. 50, 659-661.
36. Niehrs, C. (2012). The complex world of WNT receptor signalling. Nat. Rev. Mol. Cell Biol. 13, 767-779.
37. Pan, W., Choi, S. C., Wang, H., Qin, Y., Volpicelli-Daley, L., Swan, L., Lucast, L., Khoo, C., Zhang, X., Li, L. et al. (2008). Wnt3a-mediated formation of phosphatidylinositol 4,5-bisphosphate regulates LRP6 phosphorylation. Science 321, 1350-1353.
38. Pellegrini, M., Pilia, G., Pantano, S., Lucchini, F., Uda, M., Fumi, M., Cao, A., Schlessinger, D. and Forabosco, A. (1998). Gpc3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome. Dev. Dyn. 213, 431-439.
39. Roskams, T. and Kojiro, M. (2010). Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis. Semin. Liver Dis. 30, 17-25.
40. Sakane, H., Yamamoto, H., Matsumoto, S., Sato, A. and Kikuchi, A. (2012). Localization of glypican-4 in different membrane microdomains is involved in the regulation of Wnt signaling. J. Cell Sci. 125, 449-460.
41. Satoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N., Nishiwaki, T., Kawasoe, T., Ishiguro, H., Fujita, M., Tokino, T. et al. (2000). AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virusmediated transfer of AXIN1. Nat. Genet. 24, 245-250.
42. Saunders, S., Paine-Saunders, S. and Lander, A. D. (1997). Expression of the cell surface proteoglycan glypican-5 is developmentally regulated in kidney, limb, and brain. Dev. Biol. 190, 78-93.
43. Schlessinger, J., Lax, I. and Lemmon, M. (1995). Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? Cell 83, 357-360.
44. Song, H. H., Shi, W., Xiang, Y. Y. and Filmus, J. (2005). The loss of glypican-3 induces alterations in Wnt signaling. J. Biol. Chem. 280, 2116-2125.
45. Takada, R., Hijikata, H., Kondoh, H. and Takada, S. (2005). Analysis of combinatorial effects of Wnts and Frizzleds on b-catenin/armadillo stabilization and Dishevelled phosphorylation. Genes Cells 10, 919-928.
46. Thompson, M. D. and Monga, S. P. (2007). WNT/b-catenin signaling in liver health and disease. Hepatology 45, 1298-1305.
47. Topczewski, J., Sepich, D. S., Myers, D. C., Walker, C., Amores, A., Lele, Z., Hammerschmidt, M., Postlethwait, J. and Solnica-Krezel, L. (2001). The zebrafish glypican knypek controls cell polarity during gastrulation movements of convergent extension. Dev. Cell 1, 251-264.
48. Traister, A., Shi, W. and Filmus, J. (2008). Mammalian Notum induces the release of glypicans and other GPI-anchored proteins from the cell surface. Biochem. J. 410, 503-511.
49. Tsuda, M., Kamimura, K., Nakato, H., Archer, M., Staatz, W., Fox, B., Humphrey, M., Olson, S., Futch, T., Kaluza, V. et al. (1999). The cell-surface proteoglycan Dally regulates Wingless signalling in Drosophila. Nature 400, 276-280.
50. Veugelers, M., De Cat, B., Ceulemans, H., Bruystens, A. M., Coomans, C., Dürr, J., Vermeesch, J., Marynen, P. and David, G. (1999). Glypican-6, a new member of the glypican family of cell surface heparan sulfate proteoglycans. J. Biol. Chem. 274, 26968-26977.
51. Wu, Y., Belenkaya, T. Y. and Lin, X. (2010). Dual roles of Drosophila glypican Dally-like in Wingless/Wnt signaling and distribution. Methods Enzymol. 480, 33-50.
52. Yamamoto, H., Sakane, H., Yamamoto, H., Michiue, T. and Kikuchi, A. (2008). Wnt3a and Dkk1 regulate distinct internalization pathways of LRP6 to tune the activation of b-catenin signaling. Dev. Cell 15, 37-48.
53. Yamauchi, N., Watanabe, A., Hishinuma, M., Ohashi, K., Midorikawa, Y., Morishita, Y., Niki, T., Shibahara, J., Mori, M., Makuuchi, M. et al. (2005). The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma. Mod. Pathol. 18, 1591-1598.
54. Yan, D., Wu, Y., Feng, Y., Lin, S. C. and Lin, X. (2009). The core protein of glypican Dally-like determines its biphasic activity in wingless morphogen signaling. Dev. Cell 17, 470-481.
55. Zittermann, S. I., Capurro, M. I., Shi, W. and Filmus, J. (2010). Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo. Int. J. Cancer 126, 1291-1301.